Thomas Eigentler
Impact in
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
- Oncology 217
- Cutaneous Melanoma Detection and Management 141
- Cancer Immunotherapy and Biomarkers 77
- Polyomavirus and related diseases 9
- Epidemiology 40
- Nonmelanoma Skin Cancer Studies 39
- Co-authors
- Claus Garbe (151 shared papers)Ulrike Leiter (67 shared papers)Benjamin Weide (35 shared papers)Friedegund Elke Meier (47 shared papers)Ralf Gutzmer (30 shared papers)Axel Hauschild (22 shared papers)Peter Radny (13 shared papers)Helmut Breuninger (18 shared papers)
- Journals
- JDDG Journal der Deutschen Dermatologischen Gesellschaft (46 papers)European Journal of Cancer (23 papers)Annals of Oncology (18 papers)Journal for ImmunoTherapy of Cancer (12 papers)PLoS ONE (11 papers)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Thomas Eigentler
303 papers receiving 15.9k citations
Thomas Eigentler's Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 9.7k
- Immunology 1k
- Dermatology 384
- Epidemiology 1.3k
- Ophthalmology 382
Countries citing papers authored by Thomas Eigentler
This map shows the geographic impact of Thomas Eigentler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Eigentler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Eigentler more than expected).
Fields of papers citing papers by Thomas Eigentler
This network shows the impact of papers produced by Thomas Eigentler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Eigentler. The network helps show where Thomas Eigentler may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Eigentler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 318 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial Hit paper breakdown → | 2015 | 1348 |
| 2 | Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy Hit paper breakdown → | 2016 | 555 |
| 3 | Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 526 |
| 4 | Epidemiology of Skin Cancer Hit paper breakdown → | 2014 | 487 |
| 5 | Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy Hit paper breakdown → | 2016 | 484 |
| 6 | 2016 | 481 | |
| 7 | 2011 | 480 | |
| 8 | 2013 | 414 | |
| 9 | 2016 | 343 | |
| 10 | 2009 | 330 | |
| 11 | 2019 | 313 | |
| 12 | 2003 | 261 | |
| 13 | 2017 | 261 | |
| 14 | 2008 | 225 | |
| 15 | 2008 | 209 | |
| 16 | 2013 | 201 | |
| 17 | 2020 | 199 | |
| 18 | 2019 | 187 | |
| 19 | 2007 | 183 | |
| 20 | 2017 | 177 |
About Thomas Eigentler
Thomas Eigentler is a scholar working on Oncology, Epidemiology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Dermatology, having authored 318 papers that have together received 16.2k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (141 papers), Cancer Immunotherapy and Biomarkers (77 papers), Melanoma and MAPK Pathways (42 papers), Nonmelanoma Skin Cancer Studies (39 papers), Brain Metastases and Treatment (9 papers), Polyomavirus and related diseases (9 papers), Medical Imaging Techniques and Applications (8 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Oncology (9.7k citations), Immunology (1k citations), Dermatology (384 citations), Epidemiology (1.3k citations) and Ophthalmology (382 citations). Thomas Eigentler has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Claus Garbe, Ulrike Leiter, Benjamin Weide, Friedegund Elke Meier, Ralf Gutzmer, Axel Hauschild, Peter Radny, Helmut Breuninger, Annette Pflugfelder and Andrea Forschner. Their work appears in journals such as JDDG Journal der Deutschen Dermatologischen Gesellschaft, European Journal of Cancer, Annals of Oncology, Journal for ImmunoTherapy of Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.